News &amp; Updates

Exploring rapid relief with amylmetacresol/2,4-dichlorobenzyl alcohol lozenges and the broad antiseptic activity of hexetidine gargle

Beyond symptom relief at the first sign of an itchy throat

Why one cough syrup does not fit all and how to choose wisely

Cough is a very common symptom and remains a leading reason for consulting healthcare professionals.

Why one cough syrup does not fit all and how to choose wisely

Early SGLT-2 inhibitor therapy may be best for diabetic patients recovering from AKI-D

For adult patients with type 2 diabetes who are recovering from dialysis-requiring acute kidney injury (AKI-D), initiating sodium-glucose cotransporter-2 (SGLT-2) inhibitor therapy within 30 days of discharge is associated with fewer adverse kidney events compared with later initiation, as shown in a retrospective study.

Early SGLT-2 inhibitor therapy may be best for diabetic patients recovering from AKI-D

Early discharge of infants with tube feeding not linked to parental distress

Early discharge of very preterm infants with home nasogastric tube (NGT) feeding does not appear to increase psychological distress among parents both at discharge and at 3 months corrected age (CA), suggests a study.

Early discharge of infants with tube feeding not linked to parental distress

Early ECG monitoring does not prevent syncope recurrence, but may improve survival

Immediate ambulatory electrocardiographic (ECG) monitoring initiated among patients with syncope in the emergency department (ED) falls short of preventing recurrent syncope over 1 year, according to the ASPIRED study presented at ESC Congress 2026.

Early ECG monitoring does not prevent syncope recurrence, but may improve survival

Tailored therapy reduces antibiotic use in infective endocarditis

A response-tailored strategy decreases antibiotic duration by 2 weeks compared with standard therapy in patients with left-sided infective endocarditis, without compromising their safety. This is the primary result of the POET-II study presented at ESC Congress 2026.

Tailored therapy reduces antibiotic use in infective endocarditis

09 Sep 2026

Add-on tafasitamab–lenalidomide improves PFS in BCLs

In the global phase III frontMIND study, adding tafasitamab and lenalidomide (Tafa-Len) to an R-CHOP* chemotherapy regimen significantly improves progression-free survival in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade BCL (HGBCL).

Add-on tafasitamab–lenalidomide improves PFS in BCLs

09 Sep 2026

Adherence to inhaled therapy for asthma tied to favourable patient-reported outcomes

In adult patients with mild-to-moderate asthma, better adherence to inhaled therapy is linked to improved disease control and quality of life, according to a study.

Adherence to inhaled therapy for asthma tied to favourable patient-reported outcomes